TruAlt Bioenergy Limited Stock Price Today (NSE: TRUALT)

TruAlt Bioenergy Limited

414.450.60 (0.14%)
Market Closed

Fundamental Score

...

TruAlt Bioenergy Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

TruAlt Bioenergy Limited share price today is 414.45, down 0.14% on NSE/BSE as of 22 September 2026. TruAlt Bioenergy Limited (TRUALT) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of 3.55K (Cr). The 52-week high for TRUALT share price is 549.00 and the 52-week low is 310.20. At a P/E ratio of 25.33x, TRUALT is currently trading above its industry average P/E of 19.03x. The company has a Return on Equity (ROE) of 8.38% and a debt-to-equity ratio of 1.08.

TruAlt Bioenergy Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
494.00
Low
410.85
Volume
2.1L
Change
-11.99%

TruAlt Bioenergy Limited share price chart: -11.99% return over the past month. 52-week high ₹549.00, 52-week low ₹310.20.

TruAlt Bioenergy Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
425.05425.05412.00415.052.80L (Cr)
425.00437.65420.50421.702.20L (Cr)
422.70434.20420.10423.953.57L (Cr)
416.20427.50407.00422.704.54L (Cr)
415.00428.00400.00411.652.24L (Cr)
416.10423.95413.55416.3599.81K (Cr)
423.05424.05414.35419.6592.62K (Cr)
415.70428.60415.00421.151.20L (Cr)
424.00425.50410.85415.701.39L (Cr)
425.95433.85420.00424.1073.76K (Cr)

TruAlt Bioenergy Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
429.95437.65400.00415.05-3.47%
424.90494.00413.65429.60+1.11%
454.30475.90411.00423.00-6.89%
487.55542.00451.50453.45-6.99%
497.90515.90419.15487.55-2.08%
414.00508.00399.00492.45+18.95%
389.00418.00357.00403.40+3.70%
374.25450.80362.20401.40+7.25%
406.75417.45310.20381.85-6.12%
448.95449.00384.00403.85-10.05%
446.40488.00401.85445.80-0.13%
545.40549.00439.25446.10-18.21%

Returns & Performance

Poor

Return on Equity (ROE)

8.38%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

10.44%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

TruAlt Bioenergy Limited Valuation Check

Poor

Price to Earnings (P/E)

25.33x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.03x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

70.55%

% shares held by company founders/management

Poor

FII Holding

0.66%

% shares held by foreign institutional investors

Average

DII Holding

9.40%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

36.85%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

1109.57%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

106.29%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.08x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.81x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

TruAlt Bioenergy Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TRUALT across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Robust Profit Growth (1109.57%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (106.29%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Balanced Promoter Holding (70.55%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Risk Factors

5 factors identified

Below-Average Return on Equity (8.38%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Elevated Debt Levels (D/E: 1.08)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (1.81x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

High Share Pledging Risk (36.85%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

TruAlt Bioenergy Limited vs Other Agricultural Products Peers

Peer Comparison -

Compare TruAlt Bioenergy Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
0/100
414
₹3554.02
25.3
Average
8.38%
Poor
10.44%
Average
1.1
Average
0.00%
59.6/100
445
₹15461.44
24.1
Average
0.00%
Poor
20.11%
Excellent
0.2
Excellent
17.99%
Excellent
18.70%
Excellent
0.78%
45.2/100
428
₹9792.34
12.9
Average
11.73%
Average
15.54%
Good
0.0
Excellent
2.95%
Average
8.84%
Good
0.97%
45.1/100
166
₹7623.59
18.3
Average
9.66%
Poor
13.10%
Average
0.1
Excellent
-2.08%
Poor
4.01%
Average
0.17%
51.8/100
725
₹3731.13
15.1
Average
18.17%
Good
18.21%
Good
0.0
Excellent
-0.96%
Poor
6.12%
Good
0.59%
39.7/100
109
₹2183.93
45.4
Average
5.09%
Poor
5.51%
Poor
0.0
Excellent
19.99%
Excellent
19.85%
Excellent
0.00%
40.4/100
88
₹1815.37
13.9
Average
14.47%
Average
23.69%
Excellent
0.6
Good
10.46%
Good
18.11%
Excellent
0.00%
54.6/100
302
₹1500.73
12.0
Average
14.61%
Average
19.04%
Good
0.1
Excellent
6.96%
Good
11.07%
Good
0.89%
58.2/100
91
₹1380.91
16.5
Average
0.00%
Poor
16.93%
Good
0.2
Excellent
7.57%
Good
8.01%
Good
1.13%
58.1/100
179
₹1116.44
7.6
Average
16.09%
Good
21.93%
Excellent
0.4
Excellent
11.40%
Good
24.73%
Excellent
0.17%
53.4/100
89
₹936.25
32.3
Average
22.68%
Excellent
29.10%
Excellent
0.8
Good
35.75%
Excellent
14.96%
Good
0.00%

TruAlt Bioenergy Limited Quarterly Performance

Latest quarterly metrics for TRUALT — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

106.29%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

1109.57%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

TruAlt Bioenergy Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for TRUALT — calculated from daily price history

19RSI 14
Oversold — RSI 19

Selling pressure is heavy — potential reversal zone.

SMA 50
445
▼ Price below SMA 50 — Short-term bearish
SMA 200
433
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
239K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

TruAlt Bioenergy Limited Financial Statements

Annual income statement, balance sheet and cash flow for TruAlt Bioenergy Limited (TRUALT) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for TruAlt Bioenergy Limited

Loading latest quarterly results...

About TRUALT (TruAlt Bioenergy Limited)

TruAlt Bioenergy Limited (TRUALT) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Other Agricultural Products s...ector with a current market capitalisation of ₹3.55K (Cr). TruAlt Bioenergy Limited has delivered a Return on Equity (ROE) of 8.38% and a ROCE of 10.44%. The debt-to-equity ratio stands at 1.08, reflecting the company's capital structure. Investors tracking TRUALT share price can monitor key metrics including P/E ratio, promoter holding of 70.55%, and quarterly earnings growth.

Company Details

Symbol:TRUALT
Industry:Other Agricultural Products
Sector:N/A
Website:N/A

TRUALT Share Price: Frequently Asked Questions

What is the current share price of TruAlt Bioenergy Limited?

TruAlt Bioenergy Limited (TRUALT) trades at ₹414.45 on NSE and BSE. Market cap ₹3.55K (Cr). Educational data only.

What is the P/E ratio of TruAlt Bioenergy Limited?

TruAlt Bioenergy Limited has a P/E of 25.33x vs industry average 19.03x.

What is the Bull Run score for TruAlt Bioenergy Limited?

TruAlt Bioenergy Limited has a Bull Run score of 0/100 based on 25+ financial parameters.

Does TruAlt Bioenergy Limited pay dividends?

TruAlt Bioenergy Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of TruAlt Bioenergy Limited?

TruAlt Bioenergy Limited has ROE of 8.38%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of TruAlt Bioenergy Limited?

TruAlt Bioenergy Limited has debt-to-equity of 1.08.

Is TruAlt Bioenergy Limited a good investment?

Bull Run gives TruAlt Bioenergy Limited a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.